Table 2.
Baseline characteristics of participants who were lost to follow-up versus those who were studied.
| Baseline Characteristic | Not Studied | Studied | p Value |
|---|---|---|---|
| N (M/F) | 42 (20/22) | 57 (27/30) | 0.00 1 |
| Age (years) | 44.4 ± 2.0 | 52.1 ± 1.7 | 0.00 1 |
| BMI (kg/m2) | 25.2 ± 0.8 | 28.1 ± 0.7 | 0.00 1 |
| Waist circumference (cm) | 88 ± 2 | 96 ± 2 | 0.00 1 |
| Systolic blood pressure (mmHg) | 117 ± 2 | 125 ± 2 | 0.01 1 |
| Diastolic blood pressure (mmHg) | 75 ± 2 | 78 ± 1 | 0.04 1 |
| Fasting blood glucose (mmol/L) | 4.5 ± 0.1 | 4.8 ± 0.1 | 0.00 1 |
| Fasting insulin (mU/L) | 11.7 ± 1.1 | 14.4 ± 0.9 | 0.03 1 |
| Total cholesterol (mmol/L) 2 | 4.1 ± 0.2 | 4.9 ± 0.1 | 0.00 1 |
| Triglycerides (mmol/L) 2 | 1.1 ± 0.1 | 1.5 ± 0.1 | 0.01 1 |
| HDL-cholesterol (mmol/L) 2 | 1.1 ± 0.1 | 1.4 ± 0.0 | 0.00 1 |
| LDL-cholesterol (mmol/L) 2 | 2.5 ± 0.1 | 2.9 ± 0.1 | 0.02 1 |
Data are mean ± SEM. 1 Where the homogeneity of variances assumption was violated, the Welch statistic was used. Significance was tested using one-way Analysis of Variance (significant values highlighted in bold). 2 Data logged prior to statistical analyses. Abbreviations: HDL: high-density lipoprotein, LDL: low-density lipoprotein.